Researchers from the University of Oxford’s Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine.
Influenza is thought to be a highly variable virus, able to mutate and escape immunity built up in the population due to its circulation in previous seasons. However, influenza seasons tend to be dominated by a limited number of antigenically and genetically distinct influenza viruses. This creates a paradox as influenza is thought of as being highly variable while in reality influenza seasons are dominated by only a few strains.
Mathematical models produced in Professor Sunetra Gupta’s group at the University of Oxford over the past 20 years have sought to find an answer to this paradox. Finally, through a collaborative approach across multiple departments, the group believes they have the answer, demonstrated in a paper published today in Nature Communications.
Dr Craig Thompson said: ‘The integrated approach to vaccine design that we have applied to flu has to the potential to be applied to other previously intractable pathogens and could revolutionise the way we develop vaccines.’
Professor Sunetra Gupta said: ‘I think this work serves a good example of how evolutionary models can have translational impact. We have gone from a prediction of a mathematical model to a blueprint for a universal influenza vaccine. The outstanding teamwork coordinated by Dr Thompson is what made it all possible.’
The research team theorized that parts of the virus targeted by the immune system are, in fact, limited in variability and act as constraints on the evolution of the virus. Dr Craig Thompson in Professor Gupta’s group has now identified the location of these regions of limited variability. He has shown that such locations are targeted naturally by the immune system and through vaccination studies has shown that regions of influenza viruses that circulated in 2006 and 1977 were able to protect against infection with an influenza virus that last circulated in 1934.
The results of these studies can be exploited to create a novel type of ‘universal’ or broadly protective influenza vaccine, which once administered would provide lifelong protection against influenza. The team also hopes to apply the approach to other viruses such as HIV and HCV and believes that they can use it to produce a vaccine that protects against the common cold. The novel approach to vaccine design is outlined in the paper published in Nature Communications. Furthermore, such vaccines should be able to be produced in a low-cost manner, enabling healthcare providers such as the NHS to save money, unlike many new vaccines and drugs coming to the market.
This study also presents one of the first examples of where a mathematical model of the evolutionary dynamics of an infectious disease has led to the experimental identification of a novel vaccine target. The novel approach won an MRC Confidence in Concept Award in 2016, a Royal Society Translational Award in 2017 and an ERC Proof of Concept grant in 2018.
The WHO estimates that influenza kills 260,000-650,000 people and causes 3-5 million cases of severe illness each year. This burden typically falls on the elderly and young children, especially in developing countries. The best way to protect against influenza is through vaccination, although the problem with this is that the current influenza vaccine has to be administered each year and varies in its effectiveness.
The Latest on: Universal flu vaccine
via Google News
The Latest on: Universal flu vaccine
- Versatope Selects Influenza Vaccine Candidate for Clinical Developmenton March 18, 2020 at 5:21 pm
Versatope Therapeutics, Inc., a biotechnology company developing vaccines and therapeutics, announced today the selection of VT-105, a universal influenza vaccine candidate for clinical development. V ...
- Lessons for the Movie Industry from the 1918 Influenza Pandemicon March 17, 2020 at 4:16 pm
Second, Universal’s parent company, Comcast ... arose in the wake of a public-health crisis similar to the one the world faces now: the influenza pandemic of 1918. I’ve been reading “History of the ...
- Universal flu vaccine shows promise in phase 2 trialon March 11, 2020 at 2:06 pm
A universal influenza vaccine candidate proved to be potentially effective in a new study, according to news website Live Science. The study, published in the Annals of Internal Medicine, examined the ...
- ‘Universal’ Year-Round Flu Vaccine Now Closer To Productionon March 10, 2020 at 7:30 pm
Latest clinical trials showed that a newly developed universal year-round flu vaccine is effective to provide year-long protection against the virus with little side effects.
- A Potential Universal Flu Vaccine Just Passed an Important Clinical Trialon March 10, 2020 at 5:31 pm
There may be hope yet for a universal flu vaccine - one powerful dose of immunisation that can provide long-lasting protection for multiple influenza strains, all in a single shot. A discovery like ...
- Universal flu vaccine shows promise in phase 2b trialon March 10, 2020 at 7:44 am
A single dose of a universal influenza vaccine, adjuvanted FLU-v, may provide prolonged protection against multiple strains of the influenza virus, according to results of a phase 2b trial published ...
- A single dose of universal flu vaccine, FLU-v, may provide long-lasting protection against influenzaon March 10, 2020 at 2:35 am
A single dose of adjuvanted FLU-v, a synthetic universal flu vaccine, may provide long-lasting protection across a broad spectrum of influenza viruses. Findings from a randomized, double-blind, ...
- 'Universal' flu vaccine shows promise in clinical trialson March 10, 2020 at 12:22 am
Work is proceeding apace on a "universal" flu vaccine capable of protecting humans from all forms of influenza, researchers report. A single dose of a synthetic universal flu vaccine called FLU-v ...
- Year-Round “Universal" Flu Vaccine Proven Safe For Human Use, Clinical Trials Showon March 9, 2020 at 4:35 pm
Producing a universal year-round vaccination has proven difficult because influenza viruses mutate quickly, requiring a new vaccination every year with inactivated or attenuated viruses. Currently, ...
via Bing News